65325
8-Methoxypyrene-1,3,6-trisulfonic acid trisodium salt
suitable for fluorescence, ≥98.0% (TLC)
别名:
PTS1, Trisodium 8-methoxypyrene-1,3,6-trisulfonate
登录查看公司和协议定价
选择尺寸
关于此项目
经验公式（希尔记法）:
C17H9Na3O10S3
化学文摘社编号:
分子量:
538.41
MDL编号:
UNSPSC代码:
12352200
PubChem化学物质编号:
NACRES:
NA.32
质量水平
方案
≥98.0% (TLC)
表单
solid
mp
253-260 °C (dec.) (lit.)
溶解性
DMF: soluble
DMSO: soluble
H2O: soluble
methanol: soluble
荧光
λex 404 nm; λem 431 nm in H2O
适用性
suitable for fluorescence
SMILES字符串
[Na+].[Na+].[Na+].COc1cc(c2ccc3c(cc(c4ccc1c2c34)S([O-])(=O)=O)S([O-])(=O)=O)S([O-])(=O)=O
InChI
1S/C17H12O10S3.3Na/c1-27-12-6-13(28(18,19)20)9-4-5-11-15(30(24,25)26)7-14(29(21,22)23)10-3-2-8(12)16(9)17(10)11;;;/h2-7H,1H3,(H,18,19,20)(H,21,22,23)(H,24,25,26);;;/q;3*+1/p-3
InChI key
GUGNSJAORJLKGP-UHFFFAOYSA-K
正在寻找类似产品? 访问 产品对比指南
应用
8-Methoxypyrene-1,3,6-trisulfonic acid may be used as a fluorescent marker for studies of aerosolized drug delivery vehicles and as a highly water soluble superpolar fluorescent probe for assaying cationic surfactants
其他说明
Highly water soluble superpolar fluorescent probe for assaying cationic surfactants
储存分类代码
13 - Non Combustible Solids
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
个人防护装备
Eyeshields, Gloves, type N95 (US)
Moritz Beck-Broichsitter et al.
International journal of pharmaceutics, 367(1-2), 169-178 (2008-10-14)
The use of colloidal carrier systems for pulmonary drug delivery is an emerging field of interest in nanomedicine. The objective of this study was to compare the pulmonary absorption and distribution characteristics of the hydrophilic model drug 5(6)-carboxyfluorescein (CF) after
Kerstin Lahnstein et al.
International journal of pharmaceutics, 351(1-2), 158-164 (2007-11-06)
For the development of aerosolized controlled release formulations such as liposomes or nanoparticles, the use of suitable model drugs is necessary. This study compared the pulmonary absorption of the three structurally diverse fluorescent markers 5(6)-carboxyfluorescein (CF), 8-methoxypyrene-1,3,6-trisulfonic acid trisodium salt
Rania Salama et al.
Current drug delivery, 6(4), 404-414 (2009-06-19)
Delivering therapeutic agents to the airways maximizes their concentration in lung tissue, decreasing systemic exposure or facilitating systemic absorption as desired. Many formulations exist for the treatment of respiratory illnesses however, no controlled release inhalation formulation exists to-date. This review
S. Marhold et al.
Fresenius Journal of Analytical Chemistry, 336, 111-111 (1990)
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持